Inactive Instrument

Company Tandem Diabetes Care Inc Nasdaq

Equities

US8753721047

Medical Equipment, Supplies & Distribution

Business Summary

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.

Sales per Business

USD in Million2022Weight2023Weight Delta
Supplies and Other
54.4 %
- - 407 54.4 % -
Pump
50.1 %
432 53.9 % 374 50.1 % -13.34%
Deferral for Tandem Choice Program
-3.4 %
-4 -0.4 % -25 -3.4 % +607.44%
Pump Rebate
-1.1 %
- - -8 -1.1 % -

Sales per region

USD in Million2022Weight2023Weight Delta
United States
74.2 %
589 73.5 % 555 74.2 % -5.76%
Non-United States
25.8 %
212 26.5 % 193 25.8 % -9.23%

Managers

Managers TitleAgeSince
Chief Executive Officer 68 01/13/01
Director of Finance/CFO 51 01/13/01
Compliance Officer 58 01/22/01
Chief Tech/Sci/R&D Officer - 26/21/26
Chief Tech/Sci/R&D Officer - 01/20/01
Chief Tech/Sci/R&D Officer - 01/19/01
Chief Administrative Officer 44 01/07/01
Chief Tech/Sci/R&D Officer 60 02/21/02
Corporate Officer/Principal - 13/11
General Counsel - 02/21/02

Members of the board

Members of the board TitleAgeSince
Chairman 63 03/19/03
Director/Board Member 64 01/13/01
Chief Executive Officer 68 01/13/01
Director/Board Member 60 08/20/08
Director/Board Member 79 01/07/01
Director/Board Member 57 03/20/03
Director/Board Member 50 01/21/01
Director/Board Member 47 15/22/15
Director/Board Member 58 15/22/15

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 64,589,518 64,101,850 ( 99.24 %) 0 99.24 %

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
13.43 %
8,672,402 13.43 % 444 M $
Vanguard Fiduciary Trust Co.
10.92 %
7,052,570 10.92 % 361 M $
Capital Research & Management Co. (World Investors)
5.675 %
3,665,300 5.675 % 188 M $
Marshall Wace LLP
4.831 %
3,120,374 4.831 % 160 M $
ArrowMark Colorado Holdings LLC
4.543 %
2,934,179 4.543 % 150 M $
Jennison Associates LLC
3.957 %
2,556,124 3.957 % 131 M $
2,240,978 3.470 % 115 M $
Janus Henderson Investors US LLC
3.407 %
2,200,797 3.407 % 113 M $
Bellevue Asset Management AG
3.146 %
2,031,888 3.146 % 104 M $
BNY Mellon Investment Adviser, Inc.
2.674 %
1,726,825 2.674 % 88 M $

Company contact information

Tandem Diabetes Care, Inc.

12400 High Bluff Drive

92130, San Diego

+858 366 6900

http://www.tandemdiabetes.com
address Tandem Diabetes Care Inc
  1. Stock Market
  2. Equities
  3. TNDM Stock
  4. Stock
  5. Company Tandem Diabetes Care Inc